Last reviewed · How we verify
Acute treatment of migraine with or without aura in adults
Approved treatments
- Rimegepant for acute migraine treatment · Pfizer
Rimegepant targets the calcitonin gene-related peptide receptor to treat acute migraine. - Rimegepant/BHV3000 · Pfizer
- Rimegepant 25 MG · Pfizer
- rimegepant 75 mg ODT · Pfizer
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Acute treatment of migraine with or without aura in adults patent landscape — cliff calendar, originator estates, attackable patents
- Acute treatment of migraine with or without aura in adults treatment landscape brief
- Acute treatment of migraine with or without aura in adults treatment updates RSS
Frequently asked questions about Acute treatment of migraine with or without aura in adults
What drugs treat Acute treatment of migraine with or without aura in adults?
Tracked treatments include Rimegepant for acute migraine treatment, Rimegepant/BHV3000, Rimegepant 25 MG, rimegepant 75 mg ODT.
What is the treatment for Acute treatment of migraine with or without aura in adults?
Standard treatment for Acute treatment of migraine with or without aura in adults includes Rimegepant for acute migraine treatment, Rimegepant/BHV3000, Rimegepant 25 MG, rimegepant 75 mg ODT. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Acute treatment of migraine with or without aura in adults patent cliff · Acute treatment of migraine with or without aura in adults CI report
- Treatment: Rimegepant for acute migraine treatment · Pfizer
- Treatment: Rimegepant/BHV3000 · Pfizer
- Treatment: Rimegepant 25 MG · Pfizer
- Treatment: rimegepant 75 mg ODT · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing